Geburtsdatum
Alter
16.09.1995 (Alter: 30)
30
(16.09.1995)
Draft
Saison 19 / #11 (MEM)
Saison 19 / #11
(MEM)
Career Earnings
314.80 Mio
Gesamt
TOT
22
13181
6546
2533
813
547
223
527
2504
4228
301
835
603
851
586
716
-413
546
451
13
17
0
5964
Schnitt
AVG
24.1
12.0
4.6
1.5
1.0
0.4
1.0
4.6
7.7
0.6
1.5
1.1
1.6
1.1
1.3
-0.8
59.2%
36.0%
70.9%
24.8
20.5
0.6
0.8
0.0
10.9
16.9%
17.0
1.5
0.76
0.31
Career High
High
36
51
18
7
5
4
6
20
29
10
10
8
10
7
5
37
Gesamt
TOT
7
1284
519
181
72
46
13
43
0
32
32
83
33
54
41
51
145
46
44
1
0
0
432
Schnitt
AVG
27.9
11.3
3.9
1.6
1.0
0.3
0.9
4.2
6.1
0.7
1.8
0.7
1.2
0.9
1.1
3.2
69.1%
38.6%
61.1%
6.6
6.3
0.1
0.0
0.0
9.4
0.0%
14.8
0.0
0.00
0.00
Career High
High
33
27
7
4
3
2
4
12
13
2
5
3
6
4
6
28
Gesamt
TOT
421
217
50
26
34
1
14
63
103
26
51
13
20
4
9
221
19
19
1
0
0
177
Schnitt
AVG
22.2
11.4
2.6
1.4
1.8
0.1
0.7
3.3
5.4
1.4
2.7
0.7
1.1
0.2
0.5
11.6
61.2%
51.0%
65.0%
9.3
19.0%
19.0
1.86
3.78
0.11
Season High
High
28
51
6
5
4
1
4
15
22
7
10
2
4
2
2
36
80.0%
80.0%
66.7%
33
61.6%
67.1
1.50
2.00
0.00
41
82
ORL
37.0
22.2
11.4
2.6
1.4
1.8
0.1
0.7
3.3
5.4
1.4
2.7
0.7
1.1
0.2
0.5
11.6
61.2%
51.0%
65.0%
19
19
1
0
0
9.3
19.0%
19.0
1.86
3.78
0.11
40
82
HOU
33.0
26.2
5.8
2.4
0.5
0.8
0.0
0.4
1.9
2.6
0.6
1.6
0.3
0.4
0.3
0.6
10.9
72.5%
38.1%
75.0%
27
27
0
0
0
4.8
8.5%
8.3
1.17
1.29
0.06
39
84
UTA
16.5
27.6
10.8
4.9
1.4
1.2
0.3
0.7
4.2
6.1
0.7
1.9
0.3
1.3
0.7
1.7
7.4
68.6%
36.0%
26.5%
26
26
1
0
0
9.3
16.3%
14.4
1.95
0.73
0.18
38
83
LAL
16.5
26.9
10.7
4.4
1.6
1.0
0.2
0.9
4.2
7.4
0.5
1.5
0.7
1.4
1.6
1.1
-2.5
56.7%
35.7%
48.7%
28
28
0
0
0
10.5
16.4%
13.7
1.69
0.97
0.20
37
84
MEM
16.5
21.7
4.3
2.7
2.7
0.3
0.3
0.7
2.0
4.3
0.0
1.3
0.3
0.7
1.0
0.0
4.0
46.2%
0.0%
50.0%
3
3
0
0
0
6.6
14.2%
7.2
4.00
36
83
HOU
7.6
26.6
11.9
5.2
1.1
0.5
0.5
1.0
5.3
6.7
0.3
0.9
0.6
1.0
1.3
1.9
9.8
78.0%
30.4%
65.4%
27
27
0
0
0
9.1
15.3%
16.8
1.11
0.28
0.26
35
79
BOS
7.6
22.2
9.2
4.3
1.6
0.5
0.2
1.2
3.2
4.8
0.4
1.5
1.5
2.0
0.9
1.0
-2.8
67.6%
28.1%
77.3%
22
22
0
1
0
8.3
18.2%
14.5
1.30
0.48
0.17
34
80
MEM
7.6
16.3
4.3
2.4
0.7
0.3
0.3
0.5
1.7
3.1
0.5
0.7
0.0
0.0
0.7
0.3
-10.3
53.8%
70.6%
0.0%
26
15
0
0
0
4.2
12.7%
11.1
1.50
1.13
0.88
33
78
PHI
7.6
19.9
4.4
3.8
0.8
0.7
0.8
0.8
2.0
3.7
0.1
0.6
0.2
0.3
1.1
1.4
-13.9
54.0%
10.0%
60.0%
17
9
0
0
0
5.2
41.3%
8.8
1.00
0.52
0.57
32
80
BKN
18.5
22.7
10.5
3.4
1.8
0.6
0.5
0.4
3.7
5.2
0.6
2.0
1.2
1.4
0.5
0.7
8.4
70.9%
31.6%
87.8%
29
0
0
1
0
8.2
16.0%
17.9
4.25
0.90
0.70
31
80
DEN
18.5
27.8
16.0
5.0
3.0
1.3
0.3
0.6
5.8
8.0
1.1
2.6
1.0
1.2
0.5
1.6
8.0
72.4%
43.1%
87.9%
28
28
1
1
0
11.7
19.0%
23.0
5.19
0.78
0.20
30
79
SAC
18.5
27.9
15.0
6.5
1.5
0.8
0.5
0.7
6.0
12.4
0.4
1.4
1.7
2.4
1.8
1.0
-6.4
48.8%
28.2%
70.8%
27
27
0
2
0
15.6
23.0%
16.4
2.11
0.81
0.54
29
81
NOP
18.5
26.3
14.2
5.5
1.7
1.1
0.4
0.9
5.7
11.4
0.3
0.9
1.8
2.3
1.7
1.6
-4.0
50.2%
36.1%
80.0%
40
40
1
2
0
14.1
22.0%
17.4
1.94
0.70
0.22
28
80
NOP
17.0
27.0
19.4
5.5
2.2
1.3
0.7
1.4
7.9
13.9
0.7
2.4
1.7
2.3
1.6
1.6
-8.1
56.8%
29.6%
74.5%
41
43
2
2
0
18.7
27.0%
22.7
1.58
0.80
0.44
27
82
NOP
17.0
25.6
16.3
6.2
1.3
1.3
0.4
1.6
6.3
11.1
0.8
2.0
1.2
1.9
1.7
2.0
-4.6
56.8%
39.5%
63.4%
43
43
1
4
0
15.5
24.0%
19.5
0.81
0.65
0.20
26
82
NOP
17.0
28.1
20.1
5.9
2.0
1.4
0.4
1.3
7.5
13.3
1.0
2.9
2.1
2.9
1.5
2.0
-5.2
56.5%
34.4%
72.1%
42
42
2
4
0
18.8
28.0%
22.0
1.53
0.70
0.20
25
78
CHA
17.0
24.2
11.8
5.6
1.4
1.2
0.8
1.4
4.3
6.7
0.1
0.4
1.6
2.1
1.1
1.6
-4.8
63.6%
28.6%
76.3%
36
36
3
0
0
9.4
11.0%
17.0
1.00
0.74
0.50
24
76
CLE
6.0
12.4
6.9
2.1
0.9
0.7
0.2
1.2
2.5
3.6
0.4
1.1
0.7
0.9
0.5
1.0
-3.8
69.1%
38.1%
76.5%
19
0
1
0
0
6.3
7.0%
17.8
0.74
0.68
0.21
23
76
CLE
6.0
22.7
9.3
5.0
1.5
1.0
0.3
1.2
3.5
4.8
0.5
1.5
0.8
1.5
0.7
1.3
-2.0
72.4%
33.3%
55.6%
6
6
0
0
0
8.2
1.0%
15.7
1.29
0.75
0.25
21
74
CLE
2.5
18.5
5.4
3.8
1.2
1.0
0.6
0.9
2.1
3.8
0.1
0.3
0.9
1.1
0.5
1.2
3.8
54.1%
40.0%
80.6%
29
10
0
0
0
5.6
0.0%
12.4
1.30
0.86
0.51
20
75
CLE
2.5
5.0
2.0
2.0
0.0
0.0
0.0
0.0
1.0
3.0
0.0
0.0
0.0
0.0
0.0
1.0
-1.0
33.3%
1
0
0
0
0
3.0
0.0%
3.3
0.00
0.00
19
74
MEM
0.0
13.3
3.2
3.7
0.3
0.4
0.2
0.3
1.4
2.4
0.0
0.0
0.4
0.8
58.3%
50.0%
10
0
0
0
3.1
0.0%
10.6
1.00
2025-11-21
11-21
ORL
CLE
23
2
3
1
3
0
0
1
3
0
0
0
0
0
2
22
33.3%
--
--
x
3
5.6%
7.7
--
1.50
0.00
2025-11-01
11-01
ORL
LAC
26
5
3
3
2
0
4
2
4
0
4
1
2
0
2
-1
25.0%
0.0%
50.0%
x
13
23.3%
-1.0
0.75
1.00
0.00
2025-10-31
10-31
ORL
POR
20
22
4
0
4
0
0
4
5
4
5
2
3
0
0
18
80.0%
80.0%
66.7%
x
11
24.8%
48.5
--
--
--
2025-10-30
10-30
ORL
NOP
24
51
2
1
1
0
1
15
22
7
10
0
0
1
1
36
68.8%
70.0%
--
x
x
33
61.6%
67.1
1.00
1.00
0.00
2025-10-27
10-27
ORL
MIN
13
12
1
0
3
0
0
0
0
4
5
0
0
0
0
22
--
80.0%
--
x
5
19.0%
44.1
--
--
--
2025-10-25
10-25
ORL
LAL
21
16
4
1
0
0
1
4
5
2
4
2
2
0
0
7
66.7%
50.0%
100.0%
x
11
22.9%
25.2
1.00
--
--
2025-10-24
10-24
ORL
PHX
16
2
2
1
2
0
0
1
3
0
0
0
0
0
0
8
33.3%
--
--
x
3
9.2%
9.3
--
--
--
2025-10-23
10-23
ORL
MEM
17
6
3
0
1
0
0
3
6
0
3
0
0
2
0
21
33.3%
0.0%
--
x
9
24.3%
8.3
--
--
--
2025-10-23
10-23
ORL
BKN
23
8
4
0
1
0
0
4
5
0
2
0
0
0
0
-3
57.1%
0.0%
--
x
7
13.9%
12.3
--
--
--
2025-10-22
10-22
ORL
CHI
26
4
2
2
2
0
0
2
3
0
0
0
0
0
1
8
66.7%
--
--
x
3
5.4%
10.3
--
2.00
0.00
2025-10-21
10-21
ORL
DEN
21
10
1
0
2
1
0
1
2
2
4
2
2
0
0
16
50.0%
50.0%
100.0%
x
7
14.5%
19.8
--
--
--
2025-10-19
10-19
ORL
TOR
26
6
2
0
2
0
1
3
5
0
0
0
0
0
2
3
60.0%
--
--
x
6
10.5%
7.3
0.00
1.00
0.00
2025-10-10
10-10
ORL
NYK
28
10
4
1
4
0
3
3
5
1
4
1
2
0
0
-1
44.4%
25.0%
50.0%
x
13
19.3%
11.1
0.33
--
--
2025-10-08
10-08
ORL
DET
17
6
3
1
1
0
0
3
6
0
0
0
0
0
0
20
50.0%
--
--
x
6
16.7%
13.4
--
--
--
2025-10-03
10-03
ORL
WAS
17
8
2
1
0
0
0
4
5
0
0
0
0
1
0
23
80.0%
--
--
x
5
13.4%
19.3
--
--
--
2025-10-03
10-03
ORL
GSW
26
11
6
3
1
0
2
4
4
1
3
0
0
0
0
2
71.4%
33.3%
--
x
9
15.8%
17.3
1.50
--
--
2025-09-29
09-29
ORL
SAC
28
18
2
5
0
0
0
5
8
2
2
2
4
0
0
29
70.0%
100.0%
50.0%
x
12
19.4%
25.1
--
--
--
2025-09-27
09-27
ORL
SAS
25
11
1
3
3
0
0
3
7
1
2
2
3
0
0
10
44.4%
50.0%
66.7%
x
10
19.8%
18.4
--
--
--
2025-09-27
09-27
ORL
IND
24
9
1
3
2
0
2
1
5
2
3
1
2
0
1
-19
37.5%
66.7%
50.0%
x
11
17.9%
10.2
1.50
2.00
0.00